tirzepatide news Eli Lilly launched a four-dose, single-patient use KwikPen device for its injectable obesity drug, (Zepbound). The device gives patients an additional, potentially more convenient option for taking the drug: They can Eli Lilly plans diabetes drug

Healthcare providers should conduct a thorough evaluation of patients reporting muscle cramps on GLP-1 therapy

The really exciting shift is that these tools now extend beyond drug discovery

Personalized Approach: When Genetic Testing Guides Your Treatment Plan Not every patient responds identically to semaglutide or metformin, and genetic variation in peptide pathways significantly influences treatment outcomes

When you visit a pharmacy, you'll encounter countless medicines, each with a unique name and purpose

Researchers observed similar trends in analyses restricted to women who received a GLP-1 receptor agonist prescription within 12 months of pregnancy